Medical Practice Evaluation Center

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

1 to 2 of 2 Results

Dataverse submission for Tuberculosis Preventive Treatment for Pregnant People with HIV in South Africa: a Modeling Analysis of Clinical Benefits and Risks Mar 3, 2025 - Andrea Ciaranello Dataverse Rosen, Linzy, 2025, "Dataverse submission for Tuberculosis Preventive Treatment for Pregnant People with HIV in South Africa: a Modeling Analysis of Clinical Benefits and Risks", https://doi.org/10.7910/DVN/TOZRUT, Harvard Dataverse, V1 These materials are from an analysis funded in part by the National Institutes of Health. We are sharing these on the Harvard Dataverse in compliance with the Data Sharing and Management Plan associated with support from R37 HD079214 (PI: Ciaranello). The full analysis has been published in Clin Infect Dis, and relevant components of the published...
REVAMP Clinical Trial Dataset Dec 2, 2021 - Mark Siedner Dataverse Siedner. Mark, 2021, "REVAMP Clinical Trial Dataset", https://doi.org/10.7910/DVN/SKUUOP, Harvard Dataverse, V1, UNF:6:+8OM8WiRXHVT7hNESHIeWA== [fileUNF] Data are derived from the Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa (REVAMP) clinical trial. The de-identified dataset includes include randomization allocation, baseline participant characteristics and primary and secondary outcomes.

Dataverse submission for Tuberculosis Preventive Treatment for Pregnant People with HIV in South Africa: a Modeling Analysis of Clinical Benefits and Risks

Mar 3, 2025 - Andrea Ciaranello Dataverse

Rosen, Linzy, 2025, "Dataverse submission for Tuberculosis Preventive Treatment for Pregnant People with HIV in South Africa: a Modeling Analysis of Clinical Benefits and Risks", https://doi.org/10.7910/DVN/TOZRUT, Harvard Dataverse, V1

These materials are from an analysis funded in part by the National Institutes of Health. We are sharing these on the Harvard Dataverse in compliance with the Data Sharing and Management Plan associated with support from R37 HD079214 (PI: Ciaranello). The full analysis has been published in Clin Infect Dis, and relevant components of the published...

REVAMP Clinical Trial Dataset

Dec 2, 2021 - Mark Siedner Dataverse

Siedner. Mark, 2021, "REVAMP Clinical Trial Dataset", https://doi.org/10.7910/DVN/SKUUOP, Harvard Dataverse, V1, UNF:6:+8OM8WiRXHVT7hNESHIeWA== [fileUNF]

Data are derived from the Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa (REVAMP) clinical trial. The de-identified dataset includes include randomization allocation, baseline participant characteristics and primary and secondary outcomes.

Add Data

Share Dataverse

Link Dataverse

Reset Modifications